Active Ingredient: AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE
Proprietary Name: TRAVASOL 3.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 3.5%;51MG/100ML;131MG/100ML;218MG/100ML;35MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N020177
Product Number: 001
Approval Date: Oct 23, 1995
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:
Discontinued
Patent and Exclusivity Information
